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ABSTRACT: An ultraeﬃcient cap-exchange protocol
(UCEP) that can convert hydrophobic quantum dots (QDs)
into stable, biocompatible, and aggregation-free water-
dispersed ones at a ligand:QD molar ratio (LQMR) as low
as 500, some 20−200-fold less than most literature methods,
has been developed. The UCEP works conveniently with air-
stable lipoic acid (LA)-based ligands by exploiting tris(2-
carboxylethyl phosphine)-based rapid in situ reduction. The
resulting QDs are compact (hydrodynamic radius, Rh, < 4.5
nm) and bright (retaining > 90% of original ﬂuorescence),
resist nonspeciﬁc adsorption of proteins, and display good
stability in biological buﬀers even with high salt content (e.g., 2 M NaCl). These advantageous properties make them well suited
for cellular imaging and ratiometric biosensing applications. The QDs prepared by UCEP using dihydrolipoic acid (DHLA)-
zwitterion ligand can be readily conjugated with octa-histidine (His8)-tagged antibody mimetic proteins (known as Aﬃmers).
These QDs allow rapid, ratiometric detection of the Aﬃmer target protein down to 10 pM via a QD-sensitized Förster resonance
energy transfer (FRET) readout signal. Moreover, compact biotinylated QDs can be readily prepared by UCEP in a facile, one-
step process. The resulting QDs have been further employed for ratiometric detection of protein, exempliﬁed by neutravidin,
down to 5 pM, as well as for ﬂuorescence imaging of target cancer cells.
KEYWORDS: quantum dot, cap exchange, ultraeﬃciency, For̈ster resonance energy transfer, ﬂuorescence, ratiometric sensing,
cell imaging
■ INTRODUCTION
Over the past two decades, quantum dots (QDs) have been of
signiﬁcant research focus due to their unique, size-dependent,
stable, and bright ﬂuorescence, thus making them powerful
probes for a wide range of applications such as energy,
materials, biology, and medicine.1−11 Their broad absorption
and stable, narrow symmetric emission are particularly well
suited for multiplexed sensing, biodiagnostics, bioimaging,
immunoassay, cell tracking, and traﬃcking studies.3−6,9,12−20
In this regard, a robust, compact, and biocompatible QD
structure is of paramount importance. However, since most
high-quality QDs (e.g., CdSe/ZnS, CdSe/CdS/ZnS, CdSe/
ZnSe/ZnS) are prepared by an organometallic route, they are
naturally capped with hydrophobic ligands which render them
nondispersible in aqueous solution and biologically incompat-
ible.3,4,16 To produce biocompatible QDs, three main
approaches are widely employed: (1) encapsulation with
PEGylated phospholipids or amphiphilic/block copoly-
mers,4,16,21 (2) coating with silica,3 and (3) cap exchange.4,6
The ﬁrst two methods can produce stable but relatively bulky
QDs with a typical hydrodynamic radius (Rh) of >10 nm. This
large size can limit their application in bioimaging, particularly
in crowded regions such as neuronal synapses22 and more
critically in Förster resonance energy transfer (FRET)-based
applications. This is because such Rhs are already greater than
the R0 (Förster radius) values of most QD−dye FRET pairs
(i.e., 4−7 nm) prior to bioconjugation.9 Given the inverse sixth
power dependence of FRET eﬃciency (E) on the donor−
acceptor distance (r), E = 1/[1 + (r/R0)
6], such bulky QDs will
lead to diminished E and hence low sensitivity.3,19,23,24 By
contrast, cap exchange can produce compact QDs which are
better suited to FRET-based applications.12−14,17−19,25−32
Optimizing the cap-exchange process with 3-mercaptopro-
pionic acid has allowed the QD to retain high ﬂuorescence.31
However, such monodentate ligand-capped QDs often display
limited stability and/or resistance to nonspeciﬁc adsorp-
tion,25,32 especially in biological media with high salt content.
By contrast, dihydrolipoic acid (DHLA)-,28,29,33−36 bis-
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DHLA-,37,38 and multidentate polymer-based ligands39−41 can
bind in a multivalent manner to the QD surface to provide a
more robust coating. Moreover, such coating can also resist
nonspeciﬁc adsorption upon incorporating a poly(ethylene
glycol) (PEG) or zwitterion terminal group. The resulting
compact, biocompatible QDs have been demonstrated to be
powerful probes with a broad range of biomedical applica-
tions.22,33−35,39−41
Despite signiﬁcant research, two limitations still remain to be
solved for most current cap-exchange methods: (1) the
requirement for a large excess of ligand (with ligand:QD
molar ratio, LQMR, of ca. 104−105, Table 1) which limits its
use with precious or expensive ligands and (2) a sizable
reduction of ﬂuorescence over the parent hydrophobic QDs
(by ca. 15−95%, depending on the QD types and cap-exchange
procedure) which compromises their ﬂuorescence applications.
Most current cap-exchange reactions are performed in two
immiscible phases using non- or partially deprotonated ligands
which are not optimal for rapid QD−ligand transport,
exchange, or strong binding. Theoretically, a spherical 4.5 nm
diameter red-emitting (λEM ≈ 600 nm) CdSe/ZnS QD (see
Supporting Information, SI, Figure S1A) has a total surface area
of 63.6 nm2. Assuming the QD is terminated with a full Zn2+
outer layer in stable Wurtzite structure with each Zn2+
occupying a surface area of 0.126 nm2 (SI, Figure S2) then
the QD would contain 505 surface Zn2+ ions. Assuming each
thiolate binds to one Zn2+ ion, then 505 single thiolate ligands
(or 253 DHLA-based ligands which contains 2 thiol groups
each and hence a footprint of 0.252 nm2) would completely
saturate the QD surface Zn2+ ions. Note this is the theoretical
maximum number; the actual number is likely to be lower
because the QD surface may not be fully terminated with Zn2+
ions. Consistent with this proposal, the Mattoussi group
recently reported a footprint of ∼0.5 nm2 for each LA-
PEG1000-benzaldehyde ligand on a CdSe/ZnS QD surface,
about twice that of our estimate. The slightly bigger footprint
value is reasonable considering the possible steric eﬀect of the
long PEG chain as well as the nonpure zinc layer nature of the
QD surface.42 This simple calculation reveals that only a tiny
fraction (ca. ≤ 2%) of the DHLA-ligands used in current
literature methods can actually bind to the QD, with the vast
majority remaining as free ligands. Given its strong Zn2+
binding aﬃnity, such free DHLA-ligands may etch the ZnS
protecting shell, generating surface defects (e.g., Zn2+/S2−
vacant sites as hole/electron traps respectively via electrostatic
attraction) and compromising the QD ﬂuorescence.28 Con-
sistent with this suggestion, the Hollingsworth group found that
treating an amphiphilic polymer-encapsulated QD with
moderate concentrations of deprotonated 2-mercaptoethanol
(MBE) reduced the QD surface electron trap (presumably by
thiolates occupying the S2− vacant sites) but produced new hole
traps at higher concentrations (presumably by generating new
Zn2+ vacant sites on the ZnS shell via etching).43 Moreover, we
previously found that treating a DHLA-based chelating
dendritic ligand-capped CdSe/ZnS QD with either S2− or
Zn2+ ions could signiﬁcantly enhance the QD ﬂuorescence (∼3
fold), presumably by passivating the surface electron/hole
traps.28 This conclusion is further supported by a recent report
that cap exchange using Zn2+-metalated DHLA better preserved
QD ﬂuorescence than free DHLA, presumably because the
introduced Zn2+ ions minimized the ZnS shell etching.44
On the basis of this experimental evidence, we hypothesize
that reducing the number of ligands to a level just suﬃcient for
capping the QD surface Zn2+ ions should minimize any possible
ZnS shell etching (Zn2+/S2− vacant site formation), allowing
the cap-exchanged QD to retain native ﬂuorescence. To achieve
this goal, it is vital to improve cap-exchange eﬃciency. We
recently demonstrated substantial improvement of eﬃciency by
performing a cap-exchange reaction in a homogeneous solution
using deprotonated DHLA-ligands,45 due to the greatly
improved QD−ligand transport/exchange rates and enhanced
binding aﬃnity. Despite this success, it remained a laborious
and delicate process because the DHLA-based ligands had to be
freshly prepared, puriﬁed by column chromatography, and used
in the same day to ensure a successful cap exchange. This is
because the DHLA-based ligands are air sensitive and
susceptible to oxidization to their LA forms, which results in
loss of QD binding aﬃnity.46 By contrast, the photoligation
method developed by the Mattoussi group can work directly
with the air-stable LA form of ligands.46−49 However, the
requirement for a large excess of ligands (LQMR = 2−4 × 104,
Table 1) can limit its application with precious or expensive
ligands. Thus, an eﬃcient cap-exchange method that uses the
minimum amount (ca. LQMR < 1000) of air-stable ligands
without lengthy separation and/or puriﬁcation steps and
Table 1. Comparison of Cap-Exchange Conditions and Retained Fluorescence for Some DHLA-Based Ligand-Capped QDsa
LQMR (in 103) time QD type ligand retained original QD ﬂuorescence (%) ref
∼42 ∼2 h CdSe/ZnxCd1−xS DHLA-PEG-NH2 46−62 34
∼22 ∼0.5 h CdSe/ZnS DHLA-SB 29−43 35
∼22 ∼0.5 h CdSe/CdS/ZnS DHLA-SB 71−85% 35
∼40 60 min (hν) CdSe/ZnS Bis(LA)-ZW 50−70 37
∼41 2 h CdSe/ZnS DHLA-Zn2+ 28−57 44
∼22−50 ∼20 min (hν) CdSe/ZnS LA-PEG/NH2/F 50−70 47
40−60 ∼30 min (hν) CdSe/ZnS LA-PEG/F 50−70 49
10−100 2 h InP/ZnS DHLA 11 50
∼10 ∼2 h CdSe/ZnS DHLA 3.4−53b 51
∼40 2.5 h CdSe/CdS DHLA-PEG ∼8 52
∼40 2.5 h CdSe/CdS/ZnS DHLA-PEG ∼26 52
98 overnight CdSe/ZnS DHLA-F 40−57% 53
0.5 ∼1 min CdSe/ZnS DHLA-PEG/ZW >90 this work
0.6 ∼1 min CdSe/ZnSe/ZnS DHLA-ZW >95 this work
ahν: photoirradiation. DHLA-F: DHLA modiﬁed with functional group. bThe retained QD ﬂuorescence varied signiﬁcantly for diﬀerent colored
QDs.
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compromising the cap-exchanged QD ﬂuorescence would be
extremely valuable for QD biomedical applications.
Herein, we report an ultraeﬃcient cap-exchange protocol
(UCEP) that satisﬁes such requirements. It is based on a rapid
reduction of LA-based ligands to their DHLA forms by tris(2-
carboxylethyl)phosphine (TCEP). After deprotonation of the
thiol groups, the in situ reduced DHLA-based ligands are
directly used to initiate cap exchange with the hydrophobic
CdSe/ZnS or CdSe/ZnSe/ZnS QDs in a homogeneous
solution. We show that UCEP can completely transform the
hydrophobic QDs into stable, aggregation-free water dis-
persions at a LQMR as low as 500, ∼20−200-fold lower than
most current literature protocols (Table 1). Moreover, the
resulting QDs are compact (Rh < 4.5 nm), retain > 90% of their
original ﬂuorescence, and resist nonspeciﬁc adsorption, making
them powerful ﬂuorescence probes for FRET-based ratiometric
sensing and cancer cell imaging.
■ RESULTS AND DISCUSSION
Our UCEP procedure is shown schematically in Figure 1A.
First, three LA-based ligands appending diﬀerent terminal
functional groups (e.g., PEG750, zwitterion, PEG600-biotin;
see Chart 1 for chemical structures) were synthesized by
following literature reported procedures.29,45,48 The ligands
were then puriﬁed by silica gel column chromatography (for
LA-PEG750 and LA-PEG600-biotin) or high-performance
liquid chromatography (HPLC, for LA-zwitterion). Details of
the synthetic procedures and spectroscopic data to conﬁrm
ligand purity and chemical identity are given in the SI.
Next, the LA−ligand (e.g., LA-ZW) was reduced quantita-
tively to its DHLA form by 1 mol equiv of TCEP·HCl in a
mixed solvent of ethanol/water (1:1 v/v). The reduction was
complete in ∼5 min and could be directly visualized by the
disappearance of the yellow color (originating from the
dithiolane ring absorption), yielding a clear colorless solution.
Then six DHLA-ligand molar equivalents of NaOH (in
ethanol) were added to deprotonate the DHLA dithiol groups
to enhance their QD binding aﬃnity.44 Six molar equivalents of
NaOH were used because each DHLA-based ligand contains
two thiol groups and each TCEP.HCl molecule contains 4 acid
groups. The in situ reduced ligand was then added directly into
a QD sample dissolved in a mixed solution of CHCl3 and
ethanol (5:2 v/v), forming a homogeneous solution. After brief
shaking, the QDs were found to rapidly rise (<1 min) to the
upper aqueous layer (note, the mixed CHCl3/EtOH/H2O
solution itself did not phase separate in the absence of the QD
and/or ligands), indicating the formation of hydrophilic QDs.
The phase separation became clearer after adding more water
followed by a brief centrifugation (20 000 × g for 60s), where
all QDs were found in the top aqueous layer, leaving the lower
CHCl3 layer colorless (Figure 1B), indicating full QD water
phase transfer. The aqueous layer was then transferred to a
centrifugal ﬁltration tube with a 30 000 MW cutoﬀ membrane.
Figure 1. (A) Schematic procedures of our UCEP to compact, biocompatible QDs capped with DHLA-based ligands. (B) Photograph of a CdSe/
ZnS QD (λEM ≈ 600 nm) after cap exchange with DHLA-ZW under LQMRs: (top layer) water, (bottom layer) CHCl3. (C) Fluorescence spectra of
a CdSe/ZnS QD prior to (10 nM in CHCl3, TOPO) and after cap exchange with DHLA-ZW (10 nM in H2O) under diﬀerent LQMRs without and
with heating (the LQMR is indicated for each sample; H stands for heating at 70 °C for 1 h). (D) Comparison of the relative ﬂuorescence intensity
of the above QDs (data shown as mean ± standard deviation, n = 3).
Chart 1. Chemical Structures of the Lipoic Acid (LA)-Based
Ligands Used in This Study
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After three rounds of centrifugation and washing with H2O to
remove unbound free ligands, a stable well-dispersed QD stock
aqueous solution was obtained.
UCEP with CdSe/ZnS Core/Shell QD. First, we
investigated how LQMR aﬀected the cap-exchange process
using the most widely used commercial hydrophobic CdSe/
ZnS core/shell QD capped with the mixed trioctylphoshine/
trioctylphoshine oxide ligands (λEM ≈ 600 nm, ∼4.5 nm core
diameter, Figure S1) and the DHLA-zwitterion (ZW) ligand
(Chart 1).
When the cap exchange was performed at a LQMR of ≥200,
all of the CdSe/ZnS QDs were fully transferred to the upper
aqueous phase (shown as a brownish color), leaving the lower
CHCl3 layer colorless. By contrast, the CHCl3 layer still
contained some untransferred QDs at a LQMR of 100,
indicating that 200 is the minimum ratio required for complete
QD water dispersion (Figure 1B). Deprotonation of the DHLA
thiol groups was essential for a successful cap exchange. The
use of the TCEP-reduced DHLA-ZW ligand directly without
thiol group deprotonation produced no observable QD phase
transfer at 200 LQMR: all the QDs were found to remain in the
organic phase. This result agrees well with earlier reports that
thiolates bind much more strongly to Zn2+ ions than do free
thiols.31,44 The use of NaOH deprotonated TCEP only in the
absence of DHLA-ZW ligand also produced no observable QD
phase transfer, suggesting that TCEP or oxidized TCEP was
not the driving force behind the rapid, eﬃcient QD phase
transfer observed here.
We subsequently investigated how LQMR aﬀected the
ﬂuorescence of the UCEP-prepared QDs. When cap exchange
was performed at LQMRs of ≤500 (i.e., ≤ the total number of
the estimated Zn2+ ions on the QD surface), all of the cap-
exchanged QDs eﬀectively retained the native ﬂuorescence of
the parent hydrophobic QD in CHCl3 (>90%, Figure 1 and
Figure S3). The level of retained ﬂuorescence here is
considerably higher than most other reports for the CdSe/
ZnS QDs (Table 1). The retained ﬂuorescence was reduced to
∼67% as LQMR was increased to 3000 (Figure 1C). This
observation that increasing the LQMR results in a lower
retained QD ﬂuorescence agrees well with our hypothesis that
excess free ligands are indeed responsible for quenching
ﬂuorescence of the cap-exchanged QD, possibly by etching its
ZnS shell. This mechanism was veriﬁed by analyzing the total
Zn2+ and Cd2+ contents of the CdSe/ZnS QD after cap
Figure 2. Hydrodynamic diameter (volume population, Dh = 2Rh) distribution histograms of a CdSe/ZnS core/shell QD (λEM ≈ 600 nm) before (A,
in hexane) and after cap exchange with DHLA-ZW at diﬀerent LQMRs: 200 (B); 300 (C); 500 (D); 1000 (E). Fitting the histograms by Gaussian
function revealed that A−C contained two diﬀerent size species while D and E contained just one species. (F) Gel electrophoresis diagram of the
CdSe/ZnS QD after cap exchange with DHLA-ZW at a LQMR of 200 (lanes 1 and 2), 500 (lanes 3 and 4), 1000 (lanes 5 and 6), and 500 mixed
with a His8-tagged Aﬃmer at a protein:QD molar ratio of 10:1 (lanes 7 and 8). Sample volumes were 5 μL for lanes 1, 3, 5, and 7 and 2 μL for lanes
2, 4, 6, and 8.
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exchange with DHLA-ZW at diﬀerent LQMRs by atomic
absorption spectroscopy: a small but measurable decrease of
the Zn2+/Cd2+ molar ratio of ca. 3.5% (from 1.96 ± 0.01 to
1.89 ± 0.02) was observed as the LQMR was increased from
500 to 10 000 (see SI, section D7, Figure S4). Heating was also
found to impact on the retained QD ﬂuorescence. For example,
at a LQMR of 3000, heating at ∼70 °C for 1 h produced a QD
displaying one-half the intensity of its nonheated counterpart
(Figure 1D). Further increasing the LQMR to 6000 with 1 h
heating using our previously reported cap-exchange proce-
dures29,30 yielded an even more severely quenched QD,
retaining just ∼10% of the original ﬂuorescence. These results
indicate that heating is likely to accelerate the ZnS shell etching
by free DHLA-ZW ligands.
The DHLA-ZW-capped CdSe/ZnS QD (abbreviated as
QD−ZW) prepared by UCEP was stable in phosphate buﬀer
saline (PBS, 10 mM phosphate, 150 mM NaCl, pH 7.4) over a
pH range of 6−10 and even with high salt conditions (e.g., 2 M
NaCl, Figure S5). The stability of our QD was broadly in line
with other DHLA−zwitterion ligand-capped QDs.47,48 Im-
portantly, the UCEP was a rapid process. Complete transfer of
the QD into the aqueous phase was observed in <1 min, which
was much faster (ca. 20−200-fold) than most literature
methods using two immiscible phases (Table 1). This greatly
improved performance was attributed to the greatly enhanced
QD−ligand exchange and transfer rates in homogeneous
solution as well as greatly enhanced aﬃnity between the QD
and the DHLA-ZW ligands after thiol deprotonation.
Interestingly, despite not being the driving force behind the
rapid QD water-phase transfer, the presence of oxidized TCEP
during the cap-exchange process did improve the retained QD
ﬂuorescence: while >90% of original ﬂuorescence was retained
for the UCEP-prepared QD in the presence of oxidized TCEP
at 500 LQMR with the DHLA-ZW ligand (Figure 1), this
number was decreased to ∼80% for a control QD under
equivalent conditions but without oxidized TCEP (Figure S6).
This result was fully consistent with a previous report by the
Reiss group with an InP/ZnS QD and other thiolated ligands.50
It is likely that, at low LQMRs, a small number of oxidized
TCEP molecules may bind to the QD surface to partially
passivate the hole traps to improve the QD ﬂuorescence while
also aiding the QD water-phase transfer from its hydrophilic
nature. At high LQMRs, ZnS shell etching by the large excess of
DHLA-based ligands becomes dominant, leading to severe
quenching of the QD ﬂuorescence. Hence, the oxidized TCEP
may play two beneﬁcial roles: improving the retained
ﬂuorescence and aiding QD phase transfer; both factors
contribute to the ultraeﬃciency of the UCEP.
The UCEP was readily applied to other DHLA-based ligands
such as DHLA-PEG750, where a LQMR of 200 was also
suﬃcient to completely water disperse the CdSe/ZnS QD (SI,
Figure S3). Again, the cap-exchanged QDs retained >90% of
their original ﬂuorescence and were stable for >1 week. Such a
gentle yet robust approach is particularly well suited for core/
shell QDs with relatively thin ZnS shells (which is the case for
most commercially available CdSe/ZnS QDs) whose ﬂuo-
rescence is highly sensitive to changes of environmental
conditions (e.g., oxidation, precipitation, etc.) and can be
badly aﬀected following cap exchange with strongly coordinat-
ing ligands.28,54 This is likely due to the ZnS shell being too
thin to completely conﬁne the exciton carriers within the core
despite its type I core/shell QD structure. The exciton carriers
can “leak” out of the thin shell (via residual wave functions that
can extend ∼0.8 nm into the shell from the simulations
reported by the Bawendi group)55 and get trapped by surface
defects (e.g., S2−/Zn2+ vacant sites) induced by cap exchange
with such strongly coordinating ligands.
The hydrodynamic radius (Rh, which equals 1/2Dh) of a QD
is critical for its biomedical applications.9,22 Hence, the Rh
values of the CdSe/ZnS QD after cap exchange with the
DHLA-ZW ligand under diﬀerent LQMRs were investigated by
dynamic light scattering (DLS, see Figure 2).45 Interestingly,
the water-dispersed QDs prepared at LQMRs of 500 and 1000
were compact (Rh < 4.5 nm) and displayed almost identical,
uniform narrow size distributions. This Rh value was
comparable to those of other well-dispersed small-molecule
ligand-capped QDs reported in the literature,35,45,50 suggesting
that these QDs formed isolated, aggregation-free water
dispersions. However, the QDs prepared at LQMRs of 200
and 300 displayed relatively large, dual-size distributions. Using
the parameters obtained from the Gaussian ﬁts, their average
Rhs were calculated as ∼11.5 and ∼8.5 nm, respectively. The
corresponding particle volumes were ∼20 or ∼8 times those of
individual QDs, suggesting the QDs prepared at 200 or 300
LQMR formed minor aggregates or clusters (see SI, Table S1).
These results suggest that a LQMR of 200 or 300 is too low to
completely displace the original ligands on the QD surface. As a
result, the residual hydrophobic ligands that remained on the
QD surface can lead to QD aggregation/clustering via
hydrophobic interactions.
The diﬀerent QD sizes were further veriﬁed by gel
electrophoresis analysis:45 the QD prepared at 200 LQMR
apparently showed evidence of aggregation and exhibited lower
gel mobility (larger sizes) than those prepared at 500 or 1000,
where the latter two displayed identical gel mobility (Figure
2F). Nevertheless, the gel mobility results are fully consistent
with the Rh measurements by DLS. Together, these results
indicate that not all of the added DHLA-ligands may have
bound to the QD or the dithiolates in each DHLA molecule
may chelate to one Zn2+ ion rather than bind to two separate
Zn2+ ions on the QD surface. Therefore, a DHLA-ligand:QD
surface Zn2+ molar ratio of ∼1:1 (rather than the original
estimate of 1:2) is required to produce compact, aggregation-
free QDs suitable for practical biomedical applications.
UCEP with CdSe/ZnSe/ZnS QD. Besides the CdSe/ZnS
core/shell QD, the UCEP was readily extended to diﬀerent
colored CdSe/ZnSe/ZnS core/shell/shell QDs with λEMs =
525, 575, and 606 nm (Figure S1B). The core/shell/shell QDs
have robust ﬂuorescence because their CdSe ﬂuorescent cores
are protected by two layers of thicker inorganic shells. This is
supported by evidence from the literature showing signiﬁcantly
higher ﬂuorescence was typically retained for the core/shell/
shell QDs over their core/shell (CdSe/ZnS) counterpart after
cap exchange with DHLA-based ligands under equivalent
conditions (Table 1).35,52 All three diﬀerent colored CdSe/
ZnSe/ZnS QDs were fully water dispersed after cap exchange
with the DHLA-ZW ligand at a LQMR of 200. Moreover, these
water-dispersed QDs also retained >95% of their original
ﬂuorescence (see SI, Figure S7). It was noticed, however, that
while a LQMR of 200 led to water dispersion, the resulting
QDs lacked long-term stability and eventually precipitated from
the aqueous solution within 1 week. Increasing the LQMR to
600 produced highly stable, biocompatible QDs that remained
visibly clear without any noticeable changes of physical
appearance or ﬂuorescence over >3 months. The UCEP-
prepared water-dispersed QDs also retained >95% of their
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original ﬂuorescence. These ﬁndings contrast with most
literature methods which report >50% ﬂuorescence reduction
even for such photochemically robust CdSe/CdS/ZnS core/
shell/shell52 or CdSe/ZnxCd1-xS alloyed shell34 QDs after cap
exchange with DHLA-based ligands (Table 1). The exception is
one example where up to 86% of original ﬂuorescence was
retained for a CdSe/CdS/ZnS QD.35 These results demon-
strate the general applicability of this UCEP approach and its
excellent ability of retaining high ﬂuorescence for cap-
exchanged QDs.
QD−Aﬃmer for Ratiometric Biosensing. The high
ﬂuorescence, compact structure, and robust stability in
biologically relevant buﬀer of the UCEP-prepared QDs make
them extremely attractive for FRET-based applications. This is
because a compact QD gives a small r value while the high QD
ﬂuorescence yields a large R0 value, both factors are strongly
beneﬁcial to improve E and hence sensitivity (E = 1/[1 + (r/
R0)
6]). Since r is not only determined by the QD but also the
biorecognition molecule (binder), the use of small binders is
also critical to improve E as reported by the Hildebrandt
group.56,57 Here, nonantibody binding proteins (known as
Aﬃmers, and ﬁrst reported as Adhirons) were employed as
binders for target proteins.58 Compared to the widely used
antibodies, Aﬃmers have advantages of high thermal stability
(typically Tm ≥ 80 °C), similar binding aﬃnities (nM Kd), high
speciﬁcity, high yield animal-free recombinant bacterial
production, and ease of incorporating site-speciﬁc functional
tags (e.g., His8, cysteine) for oriented bioconjugation to
maximize binding site accessibility.58−60 More importantly,
their small sizes (MW ≈ 12 kDa, <10% that of a whole
antibody) are especially attractive for FRET-based applications,
allowing for signiﬁcantly reduced r and thereby improved
sensitivity. To demonstrate this potential, an Aﬃmer that
speciﬁcally recognizes the yeast small ubiquitin-like modiﬁer
(SUMO) protein was employed as a proof of concept for
detecting target SUMO protein. SUMO proteins play an
important role in a number of cellular process which include
nuclear-cytosolic transport, transcriptional regulation, apopto-
sis, protein stability, and response to stress, making them useful
diagnostic markers for genotoxic stress, cancer development,
and proliferation.58
First, we studied the QD−Aﬃmer conjugation via a highly
eﬃcient His8-tag-metal aﬃnity self-assembly.
5,61 The C-
terminal His8-tagged Aﬃmer was reacted with an Alexa-647-
NHS ester dye, yielding an average labeling of 1.06 Alexa-647
dyes per Aﬃmer (see SI). The labeled Aﬃmers were then
mixed with a DHLA-ZW-capped CdSe/ZnSe/ZnS QD (λEM ≈
606 nm) at diﬀerent molar ratios but with a ﬁxed total
Aﬃmer:QD molar ratio of 12 by adjusting the number of
labeled/unlabeled Aﬃmers. This approach was used to
minimize the possible change of the QD ﬂuorescence after
conjugating with a diﬀerent number of the His8-Aﬃmers.
5 As
shown in Figure S8 (SI), the QD ﬂuorescence in PBS increased
with increasing His8-Aﬃmer:QD molar ratio initially and
became saturated at 12:1, suggesting that 12 copies of Aﬃmer
may be assembled onto each QD. The resulting ﬂuorescence
spectra was recorded at λEX = 450 nm, which corresponds to
the absorption minimum of the Alexa-647 dye to minimize dye
direct excitation. The measurements revealed a progressively
quenched QD ﬂuorescence and simultaneously enhanced
Alexa-647 FRET signal (∼667 nm) with increasing dye/QD
ratio, consistent with a QD-sensitized Alex-647 dye FRET
mechanism (Figures S9 and S10).5 The successful QD−Aﬃmer
conjugation was also veriﬁed by gel electrophoresis, which
displayed lower gel mobility than the corresponding non-
conjugated QDs (Figure 2F). The QD−Alexa-647 FRET pair
has good spectral overlap with a relatively large R0 value of ∼6.5
nm (Figure S9). Using E obtained from QD quenching (E = 1
− IDA/ID, where ID and IDA are the QD intensity in the absence
and presence of the acceptor) and a single QD in FRET
interaction with N identical acceptors model (E = 1/[1 + (r/
R0)
6/N]),12 the QD−dye distance r was calculated as ∼6.6 ±
Figure 3. (A) Fluorescence spectra of the QD−Aﬃmer (ﬁnal CQD = 0.50 nM) after incubation with diﬀerent concentration of the target SUMO
protein (Alexa-647 labeled) in PBS containing 1 mg/mL of bovine serum albumin. Inset shows the ampliﬁed FRET signals over 650−725 nm. Note
that the backgrounds of PBS and PBS+10 nM labeled SUMO protein are almost the same. (B) Plot of the integrated ﬂuorescence intensity ratio
(IDye/IQD) between the dye (over 650−750 nm) and the QD (over 560−650 nm) versus the SUMO protein concentration ﬁtted to a linear function.
Inset shows the response over 0−50 pM, and the green dashed line indicates the limit of detection (background + 3σ). (C) Schematic presentation
of the QD−Aﬃmer for detection of labeled target SUMO via QD-sensitized Alexa-647 FRET readout strategy.
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0.5 nm (see SI, Figure S10). This value matched the sum of the
Aﬃmer size (∼3 nm)58 and the radius of the CdSe/ZnSe/ZnS
QD core ∼3.5 nm (Figure S1B) very well. Importantly, a
remarkably small r/R0 value of ∼1 was realized with the QD−
Aﬃmer conjugate, suggesting it was well suited for FRET-based
ratiometric sensing.
We subsequently exploited the use of QD−Aﬃmer to detect
the target protein. All sensing experiments were performed in
PBS containing a large excess of a nontarget protein (bovine
serum albumin, BSA, 1 mg/mL) using a ﬁnal QD concentration
(CQD) of 500 pM unless stated otherwise. The DHLA-ZW
ligand-capped CdSe/ZnSe/ZnS QD each conjugated with 12
copies of unlabeled anti-SUMO Aﬃmer (His8-tagged) was ﬁrst
used to detect the target SUMO protein (Alexa-647 labeled).58
Figure 3 revealed that with increasing SUMO concentration the
QD ﬂuorescence was greatly quenched while the Alexa 647
FRET signal was enhanced simultaneously. This result was fully
consistent with a mechanism of QD-sensitized Alexa-647 FRET
being induced by the speciﬁc Aﬃmer-SUMO binding. The size
of acceptor signal enhancement was relatively small in
comparison to QD donor quenching, but the results were
similar to other QD−Alexa 647 FRET systems reported
previously.14,28 Importantly, the FRET signal of 10 pM SUMO
protein was signiﬁcantly higher than its direct excitation
background at 1000-fold higher concentration (10 nM, which
was practically the same as the PBS only, see Figure 3A inset),
suggesting that the dye direct excitation contribution was
negligible. A plot of the integrated ﬂuorescence intensity ratio
between the Alexa-647 FRET (from 650 to 750 nm) and the
QD (560−650 nm), IDye/IQD, versus the SUMO concentration
yielded a positive linear relationship over 0−500 pM (R2 =
0.957), suggesting the QD−Aﬃmer sensor can detect pM
levels of target protein ratiometrically. Moreover, the linear
increase of the IDye/IQD with the SUMO concentration also
matched what was expected from the multiple identical
acceptors in FRET interactions with a single QD donor
model,12,29 suggesting that all SUMO proteins were bound to
the QD under the same r/R0 value (see Experimental Section
for an explanation).
A distinct advantage of FRET-based sensing over other
methods is a ratiometric readout signal with internal self-
calibration function. This makes it much less sensitive to
instrument noise and/or signal ﬂuctuations, allowing for
reliable and accurate target quantitation.20,29 Moreover, the
signal of 10 pM SUMO protein was well separated from the
background by >3× standard deviation, 3σ, as indicated by the
green dashed line in Figure 3B, inset.62 This suggests a
detection limit of 10 pM for the target SUMO protein, a
sensitivity that compares favorably with some other literature
QD−FRET sensors for direct protein detection without target
ampliﬁcation (see SI, Table S2). The reasons for the excellent
sensitivity here are 2-fold: (1) the UCEP allows the QD to
retain a high ﬂuorescence (hence a large R0); (2) the small size
of the Aﬃmer binder leads to a short QD−dye distance r. Both
factors are strongly beneﬁcial for improving E and hence
sensitivity. Interestingly, the detection limit and linear dynamic
range of the QD−Aﬃmer sensor can be readily tuned by the
ﬁnal CQD. Increasing the CQD to 10 nM signiﬁcantly extended
the linear dynamic range to 1−300 nM, although the limit of
detection was reduced to ∼1 nM (see SI, Figure S11).
Moreover, the QD−Aﬃmer sensor speciﬁcally detects nM
levels of the target SUMO protein even in 50% human serum
Figure 4. (A) Fluorescence spectra of the QD−Aﬃmer sensor (0.5 nM) after mixing with the Alexa-647-labeled SUMO protein reporter (0.5 nM)
containing diﬀerent amounts of the unlabeled SUMO protein. (B) Plot of I606/I667 as a function of the unlabeled SUMO protein concentration: data
over 0−10 nM are ﬁtted by a linear function (R2 = 0.978); inset shows the response over 0−2 nM. Dashed green line shows limit of detection
(background +3σ). The scheme below shows the assay principle (the protein circled is the anti-SUMO Aﬃmer, while all others are non-SUMO
binding Aﬃmers).
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(Figure S12), demonstrating excellent sensing robustness and
the potential for clinical applications. This observation is
notable as most sensing tests reported were carried out in
“clean” buﬀers, with few demonstrating sensing in clinically
relevant solutions,20,29 especially for the QDs capped with
small-molecule ligands.
The ability to detect unlabeled protein target is more useful
for biodiagnostics because target labeling may not be feasible
for naturally occurring proteins in biological samples. To
investigate this potential, we ﬁrst conjugated each CdSe/ZnSe/
ZnS QD with 1 copy of the anti-SUMO Aﬃmer (via His8-tag
self-assembly) and then blocked it with 20 copies of a control
Aﬃmer (His8-tagged) that showed no aﬃnity to the SUMO
protein.58 An Alexa-647-labeled SUMO protein was then used
as a FRET reporter. This design can reduce the chance that an
unlabeled SUMO protein will bind to vacant Aﬃmer on the
QD surface without displacing a labeled SUMO reporter,
thereby improving sensitivity. The ﬁnal concentrations of the
QD and labeled SUMO reporter were ﬁxed at 0.5 nM each. As
expected, addition of unlabeled SUMO protein successfully
competed with the labeled SUMO bound to the QD−Aﬃmer
and generated a sizable QD ﬂuorescence recovery (Figure 4). A
plot of the peak intensity ratio between the QD (at 606 nm)
and the dye (at 667 nm), I606/I667, versus the unlabeled SUMO
concentration revealed a good positive linear relationship over a
range of 0−10 nM (R2 = 0.978) with 1 nM being clearly
detected (Figure 4). The label-free sensitivity here was lower
than that of labeled detection system (ca. 10 pM). It is likely
that multivalency may enhance the Aﬃmer-SUMO binding
signal. Moreover, not all of the QD surface target Aﬃmers may
be bound to the labeled reporter proteins due to the natural
binding−dissociation equilibrium. Thus, some of the intro-
duced unlabeled SUMO proteins may simply bind to the free
Aﬃmers on the QD surface without displacing the reporter
proteins. Nevertheless, the label-free sensitivity reported here
was comparable to most other QD−FRET-based protein
sensors (see SI, Table S2).
Preparation of QD−Biotin for Biosensing and Cancer
Cell Imaging. Besides preparing stable, biocompatible QDs
using nondirectly bioactive DHLA-ligands, the UCEP was
further extended to make biotin-functionalized QDs in one pot
by treating the CdSe/ZnSe/ZnS QD with DHLA-PEG600-
biotin and DHLA-ZW or DHLA-PEG750 spacer ligands (total
LQMR = 1000). Tuning the DHLA-PEG600-biotin/spacer
ligand molar ratio and treatment sequence allowed for ready
control of the QD surface biotin valency. The resulting
biotinylated QDs (each having ∼100 DHLA-PEG600-biotin
ligands with the rest being DHLA-ZW ligands, denoted as
QD−biotin100) were employed for the detection of neutravidin
(NAV; each labeled with 1.7 Alexa-647 dyes) by exploiting the
extremely strong biotin-NAV binding (Kd ≈ 10−15 M).63 NAV
displays lower nonspeciﬁc adsorption than avidin or
streptavidin, making it well suited for developing highly speciﬁc
sensors.64,65 With increasing amount of NAV added to QD−
Figure 5. (A) Fluorescence spectra of QD−biotin100 (CQD = 0.5 nM) after mixing with diﬀerent amounts of Alexa-647-labeled neutravidin (NAV).
(B) Relationship between the I667/I607 and the NAV concentration. Data over 0−50 nM were ﬁtted by a linear function: Y = 0.01037 + 0.0084X, R2 =
0.982 (inset shows the FRET response data over 0−1 nM, and the green dashed line indicates the limit of detection). (C) Fluorescence spectra of
0.5 nM QD−biotin100 (purple), 0.5 nM QD−ZW + 50 nM NAV (black), 0.5 nM QD−biotin100 + 50 nM NAV (red), and 50 nM NAV only (blue).
(D) Comparison of the I667/I607 ratios for the QD−biotin100 only (QD only), QD−ZW+NAV (QD−ZW/NAV), and QD−biotin100+NAV (QD−
biotin/NAV). Despite a slight reduction of QD ﬂuorescence of QD−ZW+NAV over QD−biotin100 only, their I667/I607 ratios were eﬀectively the
same, being only ∼1/87 that of the QD−biotin100+NAV.
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biotin100 (CQD = 0.5 nM), the QD ﬂuorescence was
progressively quenched while the Alexa-647 FRET signal was
enhanced concurrently before reaching saturation at ∼50 nM
(Figure 5). A control experiment using the QD capped with
DHLA-ZW ligands only (QD−ZW, 0.5 nM) after mixing with
NAV (50 nM) displayed no detectable FRET signal under
identical conditions (Figure 5C and 5D). These results conﬁrm
that the FRET signal originates from the speciﬁc biotin-NAV
binding. A plot of the I667/I607 ratio versus NAV concentration
gave a good positive linear calibration over the 0−50 nM range
(R2 = 0.982, Figure 5B). Moreover, the signal from 5 pM NAV
was well separated from background (by >3σ), suggesting a
detection limit of 5 pM. This sensitivity compared favorably
against other QD−FRET sensors for protein detection (Table
S2). The signal saturation at ≥50 nM NAV suggests that all of
the QD surface biotins may have bound to NAV, matching well
to the total biotin content expected for 0.5 nM QD−biotin100.
Using the labeled NAV as a FRET reporter, the QD−biotin/
NAV was further exploited for label-free detection of biotin.
Free biotin can compete with QD−biotin100 for binding to
NAV to reduce the amounts of NAV binding to the QD and
hence reduce the FRET signal. Indeed, a signiﬁcant QD
ﬂuorescence recovery together with a concurrently reduced
Alex-647 FRET signal was observed as free biotin was added.
Moreover, 10 nM biotin was positively detected (SI, Figure
S13), suggesting the QD−biotin sensor can be employed for
label-free detection of low nM levels of biotin, an example of a
small molecule target. The sensitivity here is comparable to a
recently reported upconverting nanoparticle-QD FRET sensor
for biotin detection (∼5 nM).66
Biotin is an important vitamin (also known as vitamin H)
necessary for cell growth, the production of fatty acids, and the
metabolism of fats and amino acids. A number of cancer cells
overexpress biotin receptors on their surfaces, making biotin an
attractive ligand for cancer targeting.67−69 Thus, we further
investigated the potential of QD−biotin for cancer cell imaging.
Two QD samples were prepared with a biotin valency of ∼70
and ∼150, respectively, with the remaining sites being occupied
by DHLA-PEG750 ligands. The QDs, abbreviated as QD−
Biotin70 and QD−Biotin150, respectively, were incubated with
the HeLa human cervical cancer cells known to overexpress
biotin receptors (see SI for details).67,69 The resulting confocal
ﬂuorescence images revealed that HeLa cells treated with the
QD−biotin displayed higher ﬂuorescence intensity than those
treated with the DHLA-PEG750 ligand-capped QD control
(red channel, Figure 6). This result showed that biotin
modiﬁcation on the QD surface enhanced the uptake by
HeLa cells, presumably via biotin receptor-mediated endocy-
tosis. Interestingly, most intracellular QDs appeared to be
located close to the cell nuclei (stained by Hoechst and
displayed in blue) without entering the nuclei.
A quantitative analysis of individual cell ﬂuorescence
intensities at the QD channel by ﬂow cytometry further
conﬁrmed that biotin functionalization could enhance cell
uptake. Cells incubated with QD−biotin150 gave the strongest
ﬂuorescence signal, while the control QD exhibited the weakest
signal (SI, Figure S14). The median ﬂuorescence intensity of
QD−biotin150-treated cells was ∼56% higher than those treated
with the control QD (capped with DHLA-PEG750 ligand
only). The level of the cell uptake enhancement observed here
was comparable to that reported for other biotinylated
nanoparticles.68 Moreover, cells pretreated with DMEM
medium containing 10 mM free biotin for 1 h followed by
incubation with QD−biotin150 in the presence of 10 mM free
biotin resulted in a signiﬁcantly lower ﬂuorescence intensity (by
∼53%) over those pretreated with cell culture medium only
followed by incubation with QD−biotin150 only (SI, Figure
S15). This result revealed that the presence of free biotin
reduces the cell uptake of QD−biotin150, presumably by
competitive binding to cell surface biotin receptors. These
results demonstrate a good potential of the biotin-modiﬁed QD
in targeted cancer cell imaging.
In summary, an UCEP has been developed that allows for
rapid, complete water dispersion of the widely used hydro-
phobic CdSe/ZnS and CdSe/ZnSe/ZnS QDs using 20−200-
fold lower amounts of the DHLA-based ligands over most
literature methods. It readily produces compact, biocompatible
QDs with excellent stability in biological buﬀers and retains
near native levels of their parent QD ﬂuorescence (>90%). The
resulting QD is readily bioconjugated with His8-tagged Aﬃmers
for robust, sensitive detection of 10 pM of a speciﬁc target
protein. It also works robustly in clinically relevant media (50%
human serum). The UCEP also allows for simple one-step
preparation of biotinylated QDs for sensitive biosensing and
targeted cancer cell imaging. Compared to other literature
reported QD cap-exchange methods for LA- or DHLA-based
ligands, the UCEP has four notable advantages: (1) it uses far
fewer ligands (by 20−200-fold), which is extremely valuable for
precious, expensive, or diﬃcult to access ligands; (2) it is a
rapid procedure; (3) it is easy to operate (using air-stable
compounds and rapid in situ reduction under ambient
conditions); and (4) it shows no compromise of the
ﬂuorescence for the cap-exchanged QDs. Therefore, we believe
the UCEP reported herein will impact signiﬁcantly in the broad
QD-based biomedical research ﬁeld, including biosensing,
bioimaging, drug delivery, clinical diagnostics, and therapeutics
and most importantly in areas involving the use of QD−FRET-
based readout strategies.
Figure 6. Confocal ﬂuorescence images of HeLa cells after 4 h
treatment with 50 nM of the DHLA-PEG750 ligand-capped control
QD (top) and two QD−biotin samples containing ∼150 (middle) or
∼70 (bottom) biotins per QD. From left to right, images are displayed
as QD ﬂuorescence image (red), DAPI ﬂuorescence (staining the
nuclei, blue), optical image DIC, and the merged ﬂuorescence and
optical images.
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■ EXPERIMENTAL SECTION
Reagents and Materials. The CdSe/ZnS core/shell QD (λEM =
∼600 nm, quantum yield ≈ 10%) was purchased commercially as dry
powders from PlasmaChem GmbH (Berlin, Germany). The QD was
capped with mixed ligands of trioctylphosphine oxide (TOPO),
hexadecylamine, and oleic acid. Three diﬀerent colored CdSe/ZnSe/
ZnS core/shell/shell QD stocks in toluene (CANdots, λEMs = ∼605,
575, and 525 nm, nominal quantum yield > 30−40%) were purchased
from Strem Chemicals UK limited (Cambridge, U.K.). The molar
concentrations of the core/shell/shell QD stocks were provided by the
supplier. Their extinction coeﬃcients at the ﬁrst exciton peaks were
calculated using the provided stock concentration and their UV−vis
absorption spectra. Neutravidin and Hoechst 33342 were purchased
from ThermoFisher. Dulbecco’s modiﬁed Eagle’s medium (DMEM),
fetal bovine serum (FBS), penicillin, typsin-EDTA, Dulbecco’s
phosphate buﬀered saline (PBS), and other chemicals and reagents
were all purchased from Sigma-Aldrich (Dorset, UK) and used as
received without further puriﬁcation unless stated otherwise. Solvents
were obtained from Fisher Scientiﬁc (Loughborough, UK) and used as
received. Ultrapure water (resistance > 18.2 MΩ·cm) puriﬁed by an
ELGA Purelab classic UVF system was used for all experiments and
making buﬀers.29
Instruments and Methods. All ﬂuorescence spectra were
measured on a Spex Fluoro Max-3 Spectroﬂuorometer using a 1.5
mL quartz cuvette under a ﬁxed excitation wavelength (λEX) of 450
nm. This wavelength corresponds to the absorption minimum of the
Alexa-647 acceptor, minimizing the FRET background due to direct
excitation of the acceptor. An excitation and emission bandwidths of 5
nm and a scan rate of 120 nm/min over 480−800 nm range were
used.29,45 Centrifugations were performed with a Thermo Scientiﬁc
Heraeus Fresco 21 microcentrifuge. UV−vis absorption spectra were
recorded on a Varian Cary 50 Bio UV−visible spectrophotometer over
200−800 nm using a 1 mL quartz cuvette with an optical path of 1 cm
or on a Nanodrop 2000 spectrophotometer (Thermo Scientiﬁc) over
the range of 200−800 nm using 1 drop of the solution with an optical
path length of 1 mm. Dynamic light scattering (DLS) was measured
using a Zetasizer Nano (Malvern) instrument as described
previously.45 Confocal ﬂuorescence imaging was recorded on a Zeiss
LSM-510 inverted laser scanning confocal microscope (Germany)
using at 488 nm excitation and collecting emission at above 570 nm.70
Flow cytometry was recorded on a BD LSRFortessa cytometer. The
samples were excited at 488 nm, the emission was collected in the
570−585/42 nm band, and the results were analyzed using the FlowJo
v10 software.
Preparation of DHLA-Zwitterion-Capped QDs. The typical
ligand exchange procedure for preparing QD−ZW is as follows:
commercial hydrophobic CdSe/ZnS or CdSe/ZnSe/ZnS QD (1 nmol,
20 μL in hexane) was precipitated by adding 500 μL of EtOH followed
by centrifugation to remove any free TOPO ligands. The QD pellet
was dissolved in 50 μL of CHCl3 and then added with 20 μL of EtOH
to make solution A. LA-ZW (0.10 M, 2 μL in H2O) was reduced to
DHLA-ZW by mixing with TCEP·HCl (0.10 M, 2 μL in H2O) for 10
min, after which NaOH (0.10 M in EtOH, 12 μL) was added to fully
deprotonate the DHLA thiol groups and also to neutralize acid groups
in TCEP·HCl (each containing 4 acid groups) to make solution B.
Solutions A and B were then mixed in a new Eppendorf tube for 1−3
min with occasional shaking by hand, after which H2O (50 μL) was
added to the reaction mixture. The QD was found to rise to the top
aqueous phase, leaving the bottom CHCl3 layer eﬀectively colorless,
indicating full QD water solubilization. The top aqueous layer was
then carefully separated from the bottom CHCl3 layer and transferred
to an Amicon ultracentrifugal tube with a 30 000 MW cutoﬀ
membrane and centrifuged for 1 min at 3000 rpm. The residue was
washed with H2O (200 μL) and followed by a brief centrifugation. The
process was repeated three times to remove any unbound free ligands,
yielding a stable QD aqueous stock solution. The QD concentration
was determined by using the corresponding ﬁrst exciton peak
absorbance and extinction coeﬃcient (e.g., 2.6 × 105 M−1·cm−1 at
∼590 nm for the 600 nm emitting CdSe/ZnS QD, and 4.9 × 105 M−1·
cm−1 at ∼589 nm for the 605 nm emitting CdSe/ZnSe/ZnS QD)
using the Beer−Lambert Law following our previously established
procedures.29,30,45
Protein Labeling. The yeast SUMO protein target and the anti-
SUMO Aﬃmer were expressed in BL21 (DE3) cells using isopropyl β-
D-1-thiogalactopyranoside (IPTG) induction and puriﬁed by Ni-NTA
resin (Qiagen) aﬃnity chromatography following the manufacturer’s
instructions. The detailed experimental procedures were described in
our recent publication.58 The anti-SUMO Aﬃmer (5 mg/mL, 12.5 μL
in PBS, MW = 13 267) in a microcentrifuge tube was ﬁrst mixed with
Alexa 647 NHS-ester (50 μg in 2 μL DMSO), and then 5 μL of
NaHCO3 (0.5 M, pH = 8.3) and 7.5 μL of PBS (10 mM phosphate,
150 mM NaCl, pH 7.4) were added and thoroughly mixed at room
temperature for 2 h (dye:protein molar ratio ≈ 8:1). The reaction
mixture was loaded onto a G25 gel ﬁtration column using PBS for
elution by gravity ﬂow. The ﬁrst eluted blue band (corresponding to
the labeled anti-SUMO Aﬃmer) was collected, and its absorption
spectrum was recorded. Using the extinction coeﬃcients of the Alexa-
647 dye (ε650 nm = 239 000 M
−1·cm−1) and Aﬃmer (ε280 nm = 7904
M−1·cm−1) and the CF280 nm of 0.03 for the Alexa-647 dye, the average
dye labeling ratio on per Aﬃmer was calculated as 1.08 with a stock
protein concentration of 86 μM.45 Similarly, the SUMO protein was
labeled with Alexa-647 NHS ester under a dye:protein molar ratio of
6.4 and yielded an average dye per protein label ratio of 0.80.
Neutravidin was also labeled with Alexa-647 NHS ester under a
dye:protein molar ratio of 7, giving an average Alexa-647 dye label per
protein of 1.67.
QD−Aﬃmer Biosensing. All sensing experiments were per-
formed in PBS containing 1 mg/mL of bovine serum albumin (BSA,
to minimize the nonspeciﬁc adsorption of the QD/proteins on
surfaces) at a ﬁnal QD concentration (CQD) of 0.50 nM at a volume of
800 μL unless otherwise stated. For labeled detection, the DHLA-ZW-
capped QD (QD−ZW) was ﬁrst mixed with the unlabeled anti-SUMO
Aﬃmer (His8-tagged) at a protein:QD molar ratio of 12 in a quartz
cuvette and incubated for 20 min. Then varying amounts of target
SUMO protein (Alexa-647 labeled) were added and incubated for
another 15 min before the ﬂuorescence spectra were recorded. For
label-free detection, the QD−ZW was ﬁrst incubated with 1 mol equiv
of the anti-SUMO Aﬃmer for 10 min and then blocked with 20 mol
equiv of a control Aﬃmer for 20 min. Then QD molar equivalent of
the Alexa-647-labeled SUMO protein (used as the FRET reporter)
mixed with varying amounts of the unlabeled SUMO protein was then
introduced and incubated for a further 20 min before the ﬂuorescence
spectra were recorded.
QD−Biotin Biosensing. The assay procedures were similar to the
QD−Aﬃmer sensing above. The biotin-functionalized QDs (each
having ∼100 DHLA-PEG600-biotin with the rest being DHLA-ZW
ligands, denoted as QD−biotin100) were mixed with diﬀerent amounts
of the Alexa-647-labeled neutravidin (NAV) and incubated for 20 min
before ﬂuorescence spectra were recorded. For biotin detection, Alexa-
647-labeled Neutravidin (50 nM) was mixed with diﬀerent amounts of
free biotin for 20 min before being added to the QD−biotin100 (CQD =
0.5 nM). After a further 20 min incubation, the resulting ﬂuorescence
spectra were recorded.
Gel Electrophoresis. A 2 or 5 μL amount of a DHLA-ZW-capped
CdSe/ZnS core/shell QD (QD−ZW, λEM ≈ 600 nm) prepared at a
LQMR of 200, 500, and 1000 was mixed with 18 or 15 μL of 60%
glycerol in H2O. A QD−Aﬃmer assembly was also prepared by mixing
the QD−ZW prepared at a LQMR of 500 with 10 mol equiv of the
His8-tagged Aﬃmer. The resulting QD−Aﬃmer conjugate was treated
in the same manner as the QD−ZW samples. Then 20 μL of each
sample was loaded onto a 0.75% agarose gel in TAE buﬀer pH 8.3.
Samples were separated at 100 mV for ∼30 min, and QDs were
visualized under UV illumination (λ = 365 nm).
Cell Culture. HeLa-adherent epithelial cells derived from human
cervical carcinoma were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS)
and 100 U mL−1 penicillin. The HeLa cells were trypsinized using
trypsin-EDTA and maintained in a humidiﬁed incubator with 5% CO2
at 37 °C.
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Laser Scanning Confocal Microscopy. A 2 mL amount of HeLa
cells (1.5 × 105 cells mL−1) was cultured for 24 h followed by
treatment with 1 mL of the serum-free DMEM with or without the
QD samples (50 nM). After incubation for 4 h, the cells were washed
three times with Dulbecco’s phosphate-buﬀered saline. Hoechst 33342
was added to a ﬁnal concentration of 5 μg mL−1 for nuclei staining.
The cells were then imaged by laser scanning confocal microscopy
(Zeiss LSM-510 inverted laser scanning confocal microscope,
Germany). The QD was excited at 488 nm and the emission above
570 nm was collected.
Flow Cytometry. A 1 mL amount of HeLa cells (3 × 105 cells/
mL) was cultured in 6-well plates for 24 h followed by treatment with
1 mL of serum-free DMEM with or without QDs (50 nm). After 4 h
incubation, the cells were washed three times with Dulbecco’s
phosphate-buﬀered saline (D-PBS). After cell detachment using 0.5
mL of trypsin-EDTA, 0.5 mL of serum-free DMEM was added to each
well and the samples were centrifuged in 2 mL microcentrifuge tubes
for 5 min at 1000 rpm. The supernatant was discarded and replaced
with 0.5 mL of serum-free DMEM. The samples were ﬁltered using
Flowmi cell strainers (40 μm) and analyzed in 5 mL Falcon plastic
tubes using a BD LSRFortessa cytometer. The samples were excited at
488 nm, and the emission was collected in the 570−585/42 nm band.
The results were analyzed using FlowJo v10 software.
Free Biotin Competition. A 1 mL amount of HeLa cells (3 × 105
cells/mL) was cultured in 6-well plates for 24 h, followed by 1 h
treatment of one set of triplicates with 10 mM free biotin in serum-free
DMEM. A 1 mL amount of serum-free DMEM with QD (50 nM)
with or without free biotin (10 mM) was then added to the wells
which had been pretreated with free biotin or incubated normally,
respectively. After a 4 h incubation, the cells were washed three times
with PBS. After cell detachment using 0.5 mL of Trypsin-EDTA, 0.5
mL of serum-free DMEM was added to each well and the samples
were centrifuged in 2 mL microcentrifuge tubes for 5 min at 1000 rpm.
The supernatant was discarded and replaced with 0.5 mL of serum-free
DMEM. The samples were ﬁltered using Flowmi cell strainers (40
μm) and analyzed in 5 mL Falcon plastic tubes using BD LSRFortessa
cytometer. The samples were excited at 488 nm, and the emission was
collected in the 586/16 nm band. The results were analyzed using
FlowJo v10 software.
Correlation between the FRET Ratio and QD-Bound Protein.
For a single QD donor in FRET interaction with N identical acceptors
(e.g., idential QD−dye distance, r), the FRET eﬃciency, E, is given in
the following equation12
= × × + = +E N R N R r r R N/( ) 1/[1 ( / ) / ]06 06 6 0 6 (1)
where R0 is the Förster radius of the QD−single dye FRET pair and r
is donor−acceptor distance. E can be measured from the enhanced
acceptor emission by
β β= + = +E I I I I I/[ ] 1/[1 / ]Dye Dye QD QD Dye (2)
where β is a correction factor for the diﬀerent donor/acceptor
quantum yield and detection eﬃciency. Assuming the shape of the QD
and dye ﬂuorescence spectra are independent of intensity then the
integrated IQD/IDye ratio should be linearly propotional to the peak
intensity ratio, e.g., IQD/IDye = αI606/I667 (α is a correction factor
between the integrated and the peak intensity ratio). Combination of
eqs 1 and 2 gives
αβ+ = + ×
= +
I I I I
r R N
1/[1 / ] 1/[1 / ]
1/[1 ( / ) / ]
QD Dye 606 667
0
6
(3)
This yields the following relationship
αβ= × =I I I I r R N/ / ( / ) /QD Dye 606 667 0 6 (4)
Hence
= ×I I N R r/ [( / ) ]QD Dye 0 6 (5)
αβ= × ×I I N R r/ [ ( / ) ]667 606 0 6 (6)
This reveals that both the FRET ratio, IDye/IQD, and the apparent
FRET ratio, I667/I606, should increase linearly with N, the number of
acceptors (proteins) bound to the QD under the same FRET distance
(or r/R0 ratio).
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